美国氧气浓缩机市场：市场规模、份额、趋势分析（按产品、应用和技术划分）、细分市场预测（2025-2033 年）

美国氧气浓缩机市场摘要

据估计，2024 年美国氧气浓缩机市值为 15.5 亿美元，预计到 2033 年将达到 30.9 亿美元，2025 年至 2033 年的复合年增长率为 7.6%。

这是由于慢性阻塞性肺病、气喘和睡眠呼吸中止症等呼吸系统疾病的日益普遍、医疗保健支出不断增加、研发投入巨大、医疗保健基础设施先进、能够获得最新技术以及新产品推出等原因造成的。

根据对联邦医疗保险（Medicare）理赔数据的分析，携带式氧气浓缩机（POC）在美国医疗保险渗透率正在稳步上升。例如，2021年POC的渗透率为22.0%，而固定式製氧机的渗透率仅为17%。这一发展趋势显示携带式氧气浓缩机（POC）的普及程度高于固定式氧气浓缩机，从而推动了美国氧气浓缩机产业的扩张。

政府的支持，例如美国联邦航空管理局（FAA）核准携带式氧气浓缩机用于航空旅行，进一步推动了该地区的成长。此外，优惠的报销政策也使美国的氧气浓缩机市场更具吸引力。例如，2024年3月，美国众议院提出了《补充氧气取得改革法案》（SOAR），旨在改革和改善联邦医疗保险受益人获得补充氧气的​​途径。此外，美国医疗保健支出的成长也推动了对呼吸系统疾病有效诊断和治疗的需求，从而促进了氧气浓缩机市场的发展。

慢性呼吸系统疾病，尤其是慢性阻塞性肺病（COPD）的日益流行，是美国氧气浓缩机市场的主要驱动力。 COPD影响超过5%的美国成年人，每年造成近500亿美元的经济损失，推动了对有效氧气疗法解决方案的需求不断增长。临床研究已证实，长期氧气疗法能够改善低氧血症患者的预后，因此氧气浓缩机已成为疾病管理的重要组成部分。

此外，传统供氧方式（例如固定式供氧系统和氧气罐）的局限性，例如限制患者活动范围且需要频繁补充氧气，正推动携带式氧气浓缩机的发展。这些设备为患者提供了更大的独立性和灵活性，同时有效应对了慢性阻塞性肺病、囊肿纤维化和心臟衰竭等疾病日益严重的低氧血症问题，从而促进了其在美国市场的普及。

目录

第一章 分析方法和范围

第二章执行摘要

第三章 市场因素、趋势与范围

• 市场关联性展望
• 市场动态
  • 市场驱动因素分析
  • 呼吸系统疾病（慢性阻塞性肺病、气喘、睡眠呼吸中止症等）盛行率不断上升
  • 居家医疗的普及
  • 氧气浓缩机的技术进步
  • 推出新世代产品并拓展业务
  • 市场限制因素分析
  • 氧气浓缩机的高成本
  • 产业机会分析
  • 产业问题分析
  • 案例研究
• 商业环境分析
  • 波特五力分析
  • 供应商的议价能力
  • 买方议价能力
  • 替代品的威胁
  • 新参与企业的威胁
  • 竞争对手之间的竞争
  • PESTEL 分析
  • 政治因素
  • 经济和社会因素
  • 技术因素
  • 环境因素
  • 法律因素

第四章：美国氧气浓缩机市场：按产品分類的估算与趋势分析

• 产品仪錶板
• 市占率变化分析：依产品划分（2024 年及 2033 年）
• 按产品分類的市场规模预测和趋势分析（2021-2033）
• 携带式/医用氧气浓缩机
• 固定式医用氧气浓缩机

第五章：美国氧气浓缩机市场：按应用分類的估算和趋势分析

• 特定用途的仪錶板
• 市场占有率变化分析：按应用领域划分（2024 年和 2033 年）
• 按应用领域分類的市场规模预测和趋势分析（2021-2033）
• 居家医疗
• 除了居家医疗之外

第六章：美国氧气浓缩机市场：依技术分類的估算与趋势分析

• 技术仪錶板
• 市场占有率变化分析：依技术划分（2024 年和 2033 年）
• 按技术分類的市场规模预测和趋势分析（2021-2033）
• 连续流型
• 脉动流型

第七章美国氧气浓缩机市场：竞争格局

• 参与企业概况
• 按产品类型分類的公司市占率分析（2021-2024）
• 氧气浓缩机市场规模（以销量计）和平均售价（ASP）趋势（2021-2024 年）
• 公司分类
• 策略规划
• 公司简介/上市公司

U.S. Oxygen Concentrator Market Summary

The U.S. oxygen concentrator market size was estimated at USD 1.55 billion in 2024 and is projected to reach USD 3.09 billion by 2033, growing at a CAGR of 7.6% from 2025 to 2033. The increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea, rising healthcare spending, significant investment in R&D, advanced healthcare infrastructure, access to the newest technology, and new product launches.

According to the analyzed Medicare claims data, the Medicare penetration rate for portable oxygen concentrators (POCs) in the U.S. has steadily risen. For instance, in 2021, the POC penetration was 22.0%, while that of stationary was 17%. This is a developing trend favoring portable oxygen concentrators (POCs) over fixed oxygen concentrators and fueling the expansion of the U.S. oxygen concentrator industry.

Government support, such as the Federal Aviation Administration's (FAA) approval of portable concentrators during plane travel, further drives the region's growth. Furthermore, favorable reimbursement policies have enhanced the attractiveness of the U.S. oxygen concentrators market. For instance, in March 2024, a U.S. Congressman introduced the Supplemental Oxygen Access Reform (SOAR) Act to reform and improve access to supplementary oxygen for Medicare beneficiaries. These policies have increased the adoption of oxygen concentrators in the U.S. In addition, rising healthcare spending in the U.S. is driving the demand for effective diagnosis and treatment of respiratory diseases, thereby boosting the market for oxygen concentrators.

The rising prevalence of chronic respiratory diseases, particularly chronic obstructive pulmonary disease (COPD), is a key driver of the U.S. oxygen concentrator market. With COPD affecting over 5% of U.S. adults and contributing to nearly USD 50 billion in annual economic costs, the demand for effective oxygen therapy solutions continues to grow. Long-term oxygen therapy has been clinically proven to improve outcomes in hypoxemic patients, making oxygen concentrators an essential part of disease management.

Moreover, limitations of traditional oxygen delivery methods, such as stationary systems and oxygen cylinders that restrict mobility and require frequent refills, accelerate the shift toward portable oxygen concentrators. These devices provide patients with greater independence and flexibility while addressing the increasing burden of COPD, cystic fibrosis, and heart failure-related hypoxemia, thereby fueling adoption across the U.S. market.

U.S. Oxygen Concentrator Market Report Segmentation

This report forecasts volume & revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. oxygen concentrator market report based on product, application, and technology:

• Product Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Portable Medical Oxygen Concentrators
• Fixed Medical Oxygen Concentrators
• Application Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Home Care
• Non-Home Care
• Technology Outlook (Volume, Unit; Revenue, USD Million, 2021 - 2033)
• Continuous Flow
• Pulse Flow

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
• 1.2. Segment Definitions
  • 1.2.1. Product
  • 1.2.2. Application
  • 1.2.3. Technology
• 1.3. Estimates and Forecast Timeline
• 1.4. Research Methodology
• 1.5. Information Procurement
  • 1.5.1. Purchased Database
  • 1.5.2. GVR's Internal Database
  • 1.5.3. Secondary Sources
  • 1.5.4. Primary Research
• 1.6. Information Analysis
  • 1.6.1. Data Analysis Models
• 1.7. Market Formulation & Data Visualization
• 1.8. Model Details
  • 1.8.1. Commodity Flow Analysis
• 1.9. List of Secondary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Snapshot
• 2.2. Segment Snapshot
• 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
  • 3.2.2. Increase in the prevalence of respiratory conditions such as COPD, asthma, and sleep apnea.
  • 3.2.3. Growing adoption of home healthcare
  • 3.2.4. Technological advancements in oxygen concentrators
  • 3.2.5. Launch of new generation products and increasing business expansion
  • 3.2.6. Market Restraint Analysis
  • 3.2.7. High cost associated with oxygen concentrators
  • 3.2.8. Industry Opportunity Analysis
  • 3.2.9. Industry Challenge Analysis
  • 3.2.10. Case Studies
• 3.3. Business Environment Analysis
  • 3.3.1. Porter's Five Forces Analysis
  • 3.3.2. Supplier power
  • 3.3.3. Buyer power
  • 3.3.4. Substitution threat
  • 3.3.5. Threat of new entrant
  • 3.3.6. Competitive rivalry
  • 3.3.7. PESTLE Analysis
  • 3.3.8. Political landscape
  • 3.3.9. Economic and Social landscape
  • 3.3.10. Technological landscape
  • 3.3.11. Environmental landscape
  • 3.3.12. Legal Landscape

Chapter 4. U.S. Oxygen Concentrator Systems Market: Product Estimates & Trend Analysis

• 4.1. Product Segment Dashboard
• 4.2. Product Market Share Movement Analysis, 2024 & 2033
• 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2021 to 2033 (USD Million, Unit Volume 000')
• 4.4. Portable Medical Oxygen Concentrators
  • 4.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.4.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')
• 4.5. Fixed Medical Oxygen Concentrators
  • 4.5.1. Market estimates and forecast 2021 to 2033 (USD Million)
  • 4.5.2. Market estimates and forecast 2021 to 2033 (Unit Volume 000')

Chapter 5. U.S. Oxygen Concentrator Market: Application Estimates & Trend Analysis

• 5.1. Application Segment Dashboard
• 5.2. Application Market Share Movement Analysis, 2024 & 2033
• 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Home Care
  • 5.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 5.5. Non-Home Care
  • 5.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 6. U.S. Oxygen Concentrator Market: Technology Estimates & Trend Analysis

• 6.1. Technology Segment Dashboard
• 6.2. Technology Market Share Movement Analysis, 2024 & 2033
• 6.3. Market Size & Forecasts and Trend Analysis, by Technology, 2021 to 2033 (USD Million)
• 6.4. Continuous flow
  • 6.4.1. Market estimates and forecast 2021 to 2033 (USD Million)
• 6.5. Pulse Flow
  • 6.5.1. Market estimates and forecast 2021 to 2033 (USD Million)

Chapter 7. U.S. Oxygen Concentrator Market: Competitive Landscape

• 7.1. Participant Overview
• 7.2. Company Market Share Analysis (2021 - 2024), by product type
  • 7.2.1. Portable Medical Oxygen Concentrators (Value USD Million)
  • 7.2.2. Fixed Medical Oxygen Concentrators (Value USD Million)
• 7.3. Volume Analysis with ASP Trends (2021 - 2024) at oxygen concentrators
  • 7.3.1. Portable Medical Oxygen Concentrators (Unit Volume 000')
  • 7.3.2. Fixed Medical Oxygen Concentrators (Unit Volume 000')
• 7.4. Company Categorization
• 7.5. Strategy Mapping
• 7.6. Company Profiles/Listing
  • 7.6.1. Respironics (a subsidiary of Koninklijke Philips N.V.) {Effective from January 25, 2024, Philips Respironics halted the sale of their POCs, with end of service scheduled for January 25, 2029.}
    • 7.6.1.1. Overview
    • 7.6.1.2. Financial performance
    • 7.6.1.3. Products benchmarking
    • 7.6.1.4. Strategic initiatives
  • 7.6.2. Direct Supply
    • 7.6.2.1. Overview
    • 7.6.2.2. Financial performance
    • 7.6.2.3. Products benchmarking
    • 7.6.2.4. Strategic initiatives
  • 7.6.3. GF Health Products, Inc.
    • 7.6.3.1. Overview
    • 7.6.3.2. Financial performance
    • 7.6.3.3. Products benchmarking
    • 7.6.3.4. Strategic initiatives
  • 7.6.4. MedaCure Inc.
    • 7.6.4.1. Overview
    • 7.6.4.2. Financial performance
    • 7.6.4.3. Products benchmarking
    • 7.6.4.4. Strategic initiatives
  • 7.6.5. Nidek Medical Products, Inc
    • 7.6.5.1. Overview
    • 7.6.5.2. Financial performance
    • 7.6.5.3. Products benchmarking
    • 7.6.5.4. Strategic initiatives
  • 7.6.6. O2 Concepts
    • 7.6.6.1. Overview
    • 7.6.6.2. Financial performance
    • 7.6.6.3. Products benchmarking
    • 7.6.6.4. Strategic initiatives
  • 7.6.7. React Health
    • 7.6.7.1. Overview
    • 7.6.7.2. Financial performance
    • 7.6.7.3. Products benchmarking
    • 7.6.7.4. Strategic initiatives
  • 7.6.8. CAIRE Inc. (Acquired by Niterra Co., Ltd., formerly known as NGK SPARK PLUG CO., LTD.)
    • 7.6.8.1. Overview
    • 7.6.8.2. Financial performance
    • 7.6.8.3. Products benchmarking
    • 7.6.8.4. Strategic initiatives
  • 7.6.9. DeVilbiss Healthcare (a subsidiary of Drive Medical)
    • 7.6.9.1. Overview
    • 7.6.9.2. Financial performance
    • 7.6.9.3. Products benchmarking
    • 7.6.9.4. Strategic initiatives
  • 7.6.10. GCE Group
    • 7.6.10.1. Overview
    • 7.6.10.2. Financial performance
    • 7.6.10.3. Products benchmarking
  • 7.6.11. Compass Health Brands
    • 7.6.11.1. Overview
    • 7.6.11.2. Financial performance
    • 7.6.11.3. Products benchmarking

List of Tables

• Table 1 List of secondary sources
• Table 2 List of abbreviations
• Table 3 US Oxygen concentrator market, product, 2021 - 2033 (USD Million)
• Table 4 US Oxygen concentrator market, product, 2021 - 2033 (Unit Volume 000')
• Table 5 US Oxygen concentrator market, by application, 2021 - 2033 (USD Million)
• Table 6 US Oxygen concentrator market, by technology, 2021 - 2033 (USD Million)

List of Figures

• Fig. 1 US Oxygen Concentrator Market Segmentation
• Fig. 2 Market research process
• Fig. 3 Data triangulation techniques
• Fig. 4 Primary research pattern
• Fig. 5 Market formulation & validation
• Fig. 6 Market research approaches
• Fig. 7 Value-chain-based sizing & forecasting
• Fig. 8 QFD modelling for market share assessment
• Fig. 9 Commodity flow analysis
• Fig. 10 Market snapshot
• Fig. 11 Market segmentation (USD Million)
• Fig. 12 Competitive landscape
• Fig. 13 Parent market outlook (In USD Million)
• Fig. 14 Related/ancillary market outlook (In USD Million)
• Fig. 15 US oxygen concentrator market dynamics
• Fig. 16 US oxygen concentrator market: Porter's five forces analysis
• Fig. 17 US oxygen concentrator market: PESTLE analysis
• Fig. 18 US oxygen concentrator market: Product segment dashboard
• Fig. 19 US oxygen concentrator market: Product market share analysis, 2024 & 2033
• Fig. 20 Portable medical oxygen concentrators market, 2021 - 2033 (USD Million)
• Fig. 21 Portable medical oxygen concentrators market, 2021 - 2033 (Unit Volume 000')
• Fig. 22 Fixed medical oxygen concentrators market, 2021 - 2033 (USD Million)
• Fig. 23 Fixed medical oxygen concentrators market, 2021 - 2033 (Unit Volume 000')
• Fig. 24 US oxygen concentrator market: Application dashboard
• Fig. 25 US oxygen concentrator market: Application market share analysis, 2024 & 2033
• Fig. 26 Home care market, 2021 - 2033 (USD Million)
• Fig. 27 Non-home care market, 2021 - 2033 (USD Million)
• Fig. 28 US oxygen concentrator market: Technology segment dashboard
• Fig. 29 Continuous flow market, 2021 - 2033 (USD Million)
• Fig. 30 Pluse flow market, 2021 - 2033 (USD Million)
• Fig. 31 Company categorization
• Fig. 32 Company market share analysis
• Fig. 33 Strategic framework